Cigarette smoke condensate induces cytochromes P450 and aldo-keto reductases in oral cancer cells

Toxicology Letters

Volumn 165, Issue 2, 2006, Pages 182-194

  Nagaraj, Nagathihalli S ^a   Beckers, Simone ^a   Mensah, John K ^a   Waigel, Sabine ^a   Vigneswaran, Nadarajah ^b   Zacharias, Wolfgang ^a  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Aldo keto reductases; Cigarette smoke condensate; Cytochrome P450; Gene expression; Microarray; Oral cancer

Indexed keywords

ALDEHYDE KETONE REDUCTASE; CARCINOGEN; CIGARETTE SMOKE CONDENSATE; CYTOCHROME P450; CYTOCHROME P450 1A1; CYTOCHROME P450 1B1; OXIDOREDUCTASE; RNA; UNCLASSIFIED DRUG; ALCOHOL DEHYDROGENASE; CARBONYL REDUCTASE (NADPH); MESSENGER RNA;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CARCINOGENESIS; CELL LINE; CELL TYPE; CONTROLLED STUDY; DISEASE SEVERITY; DNA DAMAGE; DNA MICROARRAY; DOWN REGULATION; EPIDERMIS CELL; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE INDUCTION; HUMAN; HUMAN CELL; KERATINOCYTE; MOUTH CANCER; MOUTH CAVITY; NUCLEOTIDE SEQUENCE; ORAL CARCINOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RISK ASSESSMENT; SMOKING; SQUAMOUS CELL CARCINOMA; TOBACCO; UPREGULATION; VALIDATION STUDY; BIOSYNTHESIS; CELL SURVIVAL; DRUG EFFECT; ENZYME INDUCTION; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; MIDDLE AGED; MOUTH TUMOR; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOKE; TUMOR CELL LINE;

NICOTIANA TABACUM;

AGED; ALCOHOL OXIDOREDUCTASES; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL SURVIVAL; CYTOCHROME P-450 ENZYME SYSTEM; ENZYME INDUCTION; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; KERATINOCYTES; MIDDLE AGED; MOUTH NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SMOKE; TOBACCO;

EID: 33746905928     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2006.03.008     Document Type: Article

References (39)

1. Alexandrie A.K., Sundberg M.I., Seidegard J., Tornling G., and Rannug A. Genetic susceptibility to lung cancer with special emphasis on CYP1A1 and GSTM1: a study on host factors in relation to age at onset, gender and histological cancer types. Carcinogenesis 15 (1994) 1785-1790
2. Almahmeed T., Boyle J.O., Cohen E.G., Carew J.F., Du B., Altorki N.K., Kopelovich L., Fang J.L., Lazarus P., Subbaramaiah K., and Dannenberg A.J. Benzo[a]pyrene phenols are more potent inducers of CYP1A1, CYP1B1 and COX-2 than benzo[a]pyrene glucuronides in cell lines derived from the human aerodigestive tract. Carcinogenesis 25 (2004) 793-799
3. Bartsch H., Nair U., Risch A., Rojas M., Wikman H., and Alexandrov K. Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers. Cancer Epidemiol. Biomarkers Prev. 9 (2000) 3-28
4. Burczynski M.E., Sridhar G.R., Palackal N.T., and Penning T.M. The reactive oxygen species and Michael acceptor-inducible human aldo-keto reductase AKR1C1 reduces the alpha, beta-unsaturated aldehyde 4-hydroxy-2-nonenal to 1,4-dihydroxy-2-nonene. J. Biol. Chem. 276 (2001) 2890-2897
5. Crofts F.G., Strickland P.T., Hayes C.L., and Sutter T.R. Metabolism of 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine (PhIP) by human cytochrome P4501B1. Carcinogenesis 18 (1997) 1793-1798
6. Fukumoto S., Yamauchi N., Moriguchi H., Hippo Y., Watanabe A., Shibahara J., Taniguchi H., Ishikawa S., Ito H., Yamamoto S., Iwanari H., Hironaka M., Ishikawa Y., Niki T., Sohara Y., Kodama T., Nishimura M., Fukayama M., Dosaka-Akita H., and Aburatani H. Overexpression of the aldo-keto reductase family protein AKR1B10 is highly correlated with smokers' non-small cell lung carcinomas. Clin. Cancer Res. 11 (2005) 1776-1785
7. Guengerich F.P. Metabolism of chemical carcinogens. Carcinogenesis 21 (2000) 345-351
8. Huang Z., Fasco M.J., Figge H.L., Keyomarsi K., and Kaminsky L.S. Expression of cytochromes P450 in human breast tissue and tumors. Drug Metab. Dispos. 24 (1996) 899-905
9. Hyndman D., and Flynn T.G. The aldo-keto reductases and their role in cancer. Adv. Exp. Med. Biol. 463 (1999) 427-434
10. Jiang H., Shen Y.M., Quinn A.M., and Penning T.M. Competing roles of cytochrome P450 1A1/1B1 and aldo-keto reductase 1A1 in the metabolic activation of (+/-)-7,8-dihydroxy-7,8-dihydro-benzo[a]pyrene in human bronchoalveolar cell extracts. Chem. Res. Toxicol. 18 (2005) 365-374
11. Kim J.H., Stansbury K.H., Walker N.J., Trush M.A., Strickland P.T., and Sutter T.R. Metabolism of benzo[a]pyrene and benzo[a]pyrene-7,8-diol by human cytochrome P450 1B1. Carcinogenesis 19 (1998) 1847-1853
12. Kim J.H., Sherman M.E., Curriero F.C., Guengerich F.P., Strickland P.T., and Sutter T.R. Expression of cytochromes P450 1A1 and 1B1 in human lung from smokers, non-smokers, and ex-smokers. Toxicol. Appl. Pharmacol. 199 (2004) 210-219
13. -ΔΔC (T)) method. Methods 25 (2001) 402-408
14. Mahadevan B., Keshava C., Musafia-Jeknic T., Pecaj A., Weston A., and Baird W.M. Altered gene expression patterns in MCF-7 cells induced by the urban dust particulate complex mixture standard reference material 1649a. Cancer Res. 65 (2005) 1251-1258
15. Murray G.I., Melvin W.T., Greenlee W.F., and Burke M.D. Regulation, function, and tissue-specific expression of cytochrome P450 CYP1B1. Annu. Rev. Pharmacol. Toxicol. 41 (2001) 297-316
16. Nebert D.W. Role of genetics and drug metabolism in human cancer risk. Mutat. Res. 247 (1991) 267-281
17. Nebert D.W., Roe A.L., Dieter M.Z., Solis W.A., Yang Y., and Dalton T.P. Role of the aromatic hydrocarbon receptor and [Ah] gene battery in the oxidative stress response, cell cycle control, and apoptosis. Biochem. Pharmacol. 59 (2000) 65-85
18. Nebert D.W., Dalton T.P., Okey A.B., and Gonzalez F.J. Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer. J. Biol. Chem. 279 (2004) 23847-23850
19. Palackal N.T., Lee S.H., Harvey R.G., Blair I.A., and Penning T.M. Activation of polycyclic aromatic hydrocarbon trans-dihydrodiol proximate carcinogens by human aldo-keto reductase (AKR1C) enzymes and their functional overexpression in human lung carcinoma (A549) cells. J. Biol. Chem. 277 (2002) 24799-24808
20. Pelkonen O., and Nebert D.W. Metabolism of polycyclic aromatic hydrocarbons: etiologic role in carcinogenesis. Pharmacol. Rev. 34 (1982) 189-222
21. Penning T.M., Burczynski M.E., Jez J.M., Hung C.F., Lin H.K., Ma H., Moore M., Palackal N., and Ratnam K. Human 3alpha-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones. Biochem. J. 351 (2000) 67-77
22. Penning T.M. Aldo-keto reductases and formation of polycyclic aromatic hydrocarbon o-quinones. Methods Enzymol. 378 (2004) 31-67
23. Penning T.M. AKR1B10: a new diagnostic marker of non-small cell lung carcinoma in smokers. Clin. Cancer Res. 11 (2005) 1687-1690
24. Port J.L., Yamaguchi K., Du B., De Lorenzo M., Chang M., Heerdt P.M., Kopelovich L., Marcus C.B., Altorki N.K., Subbaramaiah K., and Dannenberg A.J. Tobacco smoke induces CYP1B1 in the aerodigestive tract. Carcinogenesis 25 (2004) 2275-2281
25. Roberts-Thompson S.J., McManus M.E., Tukey R.H., Gonzalez F.F., and Holder G.M. The catalytic activity of four expressed human cytochrome P450s towards benzo[a]pyrene and the isomers of its proximate carcinogen. Biochem. Biophys. Res. Commun. 192 (1993) 1373-1379
26. Rubin H. Synergistic mechanisms in carcinogenesis by polycyclic aromatic hydrocarbons and by tobacco smoke: a bio-historical perspective with updates. Carcinogenesis 22 (2001) 1903-1930
27. Shehin S.E., Stephenson R.O., and Greenlee W.F. Transcriptional regulation of the human CYP1B1 gene. J. Biol. Chem. 275 (2000) 6770-6776
28. Shimada T., Hayes C.L., Yamazaki H., Amin S., Hecht S.S., Guengerich F.P., and Sutter T.R. Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1. Cancer Res. 56 (1996) 2979-2984
29. Shimada T., Tsumura F., and Yamazaki H. Prediction of human liver microsomal oxidations of 7-ethoxycoumarin and chlorzoxazone with kinetic parameters of recombinant cytochrome P-450 enzymes. Drug Metab. Dispos. 27 (1999) 1274-1280
30. Shimada T., and Fujii-Kuriyama Y. Metabolic activation of polycyclic aromatic hydrocarbons to carcinogens by cytochromes P450 1A1 and 1B1. Cancer Sci. 95 (2004) 1-6
31. Slattery M.L., Samowtiz W., Ma K., Murtaugh M., Sweeney C., Levin T.R., and Neuhausen S. CYP1A1, cigarette smoking, and colon and rectal cancer. Am. J. Epidemiol. 160 (2004) 842-852
32. Sudbo J., and Reith A. The evolution of predictive oncology and molecular-based therapy for oral cancer prevention. Int. J. Cancer 115 (2005) 339-345
33. Thier R., Bruning T., Roos P.H., and Bolt H.M. Cytochrome P450 1B1, a new keystone in gene-environment interactions related to human head and neck cancer?. Arch Toxicol. 76 (2002) 249-256
34. Warnakulasuriya S., Sutherland G., and Scully C. Tobacco, oral cancer, and treatment of dependence. Oral Oncol. 41 (2005) 244-260
35. Wen X., and Walle T. Preferential induction of CYP1B1 by benzo[a]pyrene in human oral epithelial cells: impact on DNA adduct formation and prevention by polyphenols. Carcinogenesis 26 (2005) 1774-1781
36. Whitlock J.P. Induction of cytochrome P4501A1. Annu. Rev. Pharmacol. Toxicol. 39 (1999) 103-125
37. Willey J.C., Coy E.L., Frampton M.W., Torres A., Apostolakos M.J., Hoehn G., Schuermann W.H., Thilly W.G., Olson D.E., Hammersley J.R., Crespi C.L., and Utell M.J. Quantitative RT-PCR measurement of cytochromes p450 1A1, 1B1, and 2B7, microsomal epoxide hydrolase, and NADPH oxidoreductase expression in lung cells of smokers and nonsmokers. Am. J. Respir. Cell Mol. Biol. 17 (1997) 114-124
38. Yang C.K., Sakai S., Akutagawa T., and Matsumoto Y. CYP1A1 inducing potential of airborne particulate extracts collected during a 25-year period (1975-2000). Asian Pac. J. Cancer Prev. 6 (2005) 153-158
39. Yu D., Berlin J.A., Penning T.M., and Field J. Reactive oxygen species generated by PAH o-quinones cause change-in-function mutations in p53. Chem. Res. Toxicol. 15 (2002) 832-842